Atnaujinkite slapukų nuostatas

El. knyga: 2021 Nelson's Pediatric Antimicrobial Therapy

Consultant editor , Consultant editor , Edited by , Consultant editor , Consultant editor , Edited by , Consultant editor , Consultant editor , Consultant editor
  • Formatas: 362 pages
  • Išleidimo metai: 26-Jan-2021
  • Leidėjas: American Academy of Pediatrics
  • Kalba: eng
  • ISBN-13: 9781610024457
  • Formatas: 362 pages
  • Išleidimo metai: 26-Jan-2021
  • Leidėjas: American Academy of Pediatrics
  • Kalba: eng
  • ISBN-13: 9781610024457

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children, including COVID-19. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices.

Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

New in the 27th edition:
  • Continuous updates of drug and dosing changes
  • 4 new chapters
  • Reorganized chapter order to improve functionality


Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest recommendations for treatment of all infectious diseases in children, including COVID-19.
 
Introduction vii
Notable Changes to 2027 Nelson's Pediatric Antimicrobial Therapy, 27th Edition xi
1 Antimicrobial Therapy According to Clinical Syndromes
1(70)
A Skin and Soft Tissue Infections
4(6)
B Skeletal Infections
10(3)
C Eye Infections
13(4)
D Ear and Sinus Infections
17(3)
E Oropharyngeal Infections
20(3)
F Lower Respiratory Tract Infections
23(13)
G Cardiovascular Infections
36(8)
H Gastrointestinal Infections
44(6)
I Genital and Sexually Transmitted Infections
50(5)
J Central Nervous System Infections
55(5)
K Urinary Tract Infections
60(2)
L Miscellaneous Systemic Infections
62(9)
2 Antimicrobial Therapy for Neonates
71(32)
A Recommended Therapy for Selected Neonatal Conditions
74(21)
B Antimicrobial Dosages for Neonates
95(4)
C Aminoglycosides
99(1)
D Vancomycin
100(1)
E Use of Antimicrobials During Pregnancy or Breastfeeding
100(3)
3 Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
103(28)
A Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
104(2)
B Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
106(2)
C Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
108(2)
D Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
110(21)
4 Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
131(8)
5 Preferred Therapy for Specific Fungal Pathogens
139(20)
A Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
140(2)
B Systemic Infections
142(14)
C Localized Mucocutaneous Infections
156(3)
6 Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
159(10)
7 Preferred Therapy for Specific Viral Pathogens
169(18)
A Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
170(1)
B Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
171(1)
C Preferred Therapy for Specific Viral Pathogens
172(15)
8 Choosing Among Antiviral Agents
187(4)
9 Preferred Therapy for Specific Parasitic Pathogens
191(26)
A Selected Common Pathogenic Parasites and Suggested Agents for Treatment
192(2)
B Preferred Therapy for Specific Parasitic Pathogens
194(23)
10 Choosing Among Antiparasitic Agents: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and Neglected Tropical Diseases
217(2)
11 How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
219(4)
12 Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus
223(8)
13 Antibiotic Therapy for Children Who Are Obese
231(4)
14 Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
235(2)
15 Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
237(16)
A Postexposure Antimicrobial Prophylaxis to Prevent Infection
239(6)
B Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
245(2)
C Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
247(1)
D Surgical/Procedure Prophylaxis
248(5)
16 Approach to Antibiotic Allergies
253(10)
17 Antibiotic Stewardship
263(6)
18 Alphabetic Listing of Antimicrobials
269(34)
A Systemic Antimicrobials With Dosage Forms and Usual Dosages
271(24)
B Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
295(8)
Appendix: Nomogram for Determining Body Surface Area 303(2)
References 305(26)
Index 331